ACUITY: ACT-01 in Patients With Acute Optic Neuritis (clinicaltrials.gov) - Feb 24, 2022 - P2 | N=36 | Recruiting | Sponsor: Accure Therapeutics | Trial completion date: Dec 2022 ➔ Mar 2024 | Trial primary completion date: Aug 2021 ➔ Oct 2023
Trial completion date • Trial primary completion date • Ocular Inflammation • Ophthalmology • Optic Neuritis
|